Hypoxia‐inducible transcription factor 2α promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis
dc.contributor.author | Qu, Aijuan | en_US |
dc.contributor.author | Taylor, Matthew | en_US |
dc.contributor.author | Xue, Xiang | en_US |
dc.contributor.author | Matsubara, Tsutomu | en_US |
dc.contributor.author | Metzger, Daniel | en_US |
dc.contributor.author | Chambon, Pierre | en_US |
dc.contributor.author | Gonzalez, Frank J. | en_US |
dc.contributor.author | Shah, Yatrik M. | en_US |
dc.date.accessioned | 2011-11-10T15:33:35Z | |
dc.date.available | 2012-10-01T18:34:26Z | en_US |
dc.date.issued | 2011-08 | en_US |
dc.identifier.citation | Qu, Aijuan; Taylor, Matthew; Xue, Xiang; Matsubara, Tsutomu; Metzger, Daniel; Chambon, Pierre; Gonzalez, Frank J.; Shah, Yatrik M. (2011). "Hypoxia‐inducible transcription factor 2α promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis ." Hepatology 54(2): 472-483. <http://hdl.handle.net/2027.42/86905> | en_US |
dc.identifier.issn | 0270-9139 | en_US |
dc.identifier.issn | 1527-3350 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/86905 | |
dc.description.abstract | Oxygen dynamics in the liver is a central signaling mediator controlling hepatic homeostasis, and dysregulation of cellular oxygen is associated with liver injury. Moreover, the transcription factor relaying changes in cellular oxygen levels, hypoxia‐inducible factor (HIF), is critical in liver metabolism, and sustained increase in HIF signaling can lead to spontaneous steatosis, inflammation, and liver tumorigenesis. However, the direct responses and genetic networks regulated by HIFs in the liver are unclear. To help define the HIF signal‐transduction pathway, an animal model of HIF overexpression was generated and characterized. In this model, overexpression was achieved by Von Hippel‐Lindau ( Vhl ) disruption in a liver‐specific temporal fashion. Acute disruption of Vhl induced hepatic lipid accumulation in an HIF‐2α–dependent manner. In addition, HIF‐2α activation rapidly increased liver inflammation and fibrosis, demonstrating that steatosis and inflammation are primary responses of the liver to hypoxia. To identify downstream effectors, a global microarray expression analysis was performed using livers lacking Vhl for 24 hours and 2 weeks, revealing a time‐dependent effect of HIF on gene expression. Increase in genes involved in fatty acid synthesis were followed by an increase in fatty acid uptake‐associated genes, and an inhibition of fatty acid β‐oxidation. A rapid increase in proinflammatory cytokines and fibrogenic gene expression was also observed. In vivo chromatin immunoprecipitation assays revealed novel direct targets of HIF signaling that may contribute to hypoxia‐mediated steatosis and inflammation. Conclusion: These data suggest that HIF‐2α is a critical mediator in the progression from clinically manageable steatosis to more severe steatohepatitis and liver cancer, and may be a potential therapeutic target. (H EPATOLOGY 2011;) | en_US |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.title | Hypoxia‐inducible transcription factor 2α promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Department of Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Department of Molecular and Integrative Physiology, Department of Internal Medicine, Division of Gastroenterology, University of Michigan, 1301 East Catherine Street, Ann Arbor, MI 48109 | en_US |
dc.contributor.affiliationother | Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD | en_US |
dc.contributor.affiliationother | Department of Physiological Genetics, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France | en_US |
dc.identifier.pmid | 21538443 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/86905/1/24400_ftp.pdf | |
dc.identifier.doi | 10.1002/hep.24400 | en_US |
dc.identifier.source | Hepatology | en_US |
dc.identifier.citedreference | Jungermann K. Metabolic zonation of liver parenchyma. Semin Liver Dis 1988; 8: 329 ‐ 341. | en_US |
dc.identifier.citedreference | Jungermann K, Kietzmann T. Oxygen: modulator of metabolic zonation and disease of the liver. HEPATOLOGY 2000; 31: 255 ‐ 260. | en_US |
dc.identifier.citedreference | Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, et al. HIFalpha targeted for VHL‐mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001; 292: 464 ‐ 468. | en_US |
dc.identifier.citedreference | Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, et al. Targeting of HIF‐alpha to the von Hippel‐Lindau ubiquitylation complex by O2‐regulated prolyl hydroxylation. Science 2001; 292: 468 ‐ 472. | en_US |
dc.identifier.citedreference | Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992; 12: 5447 ‐ 5454. | en_US |
dc.identifier.citedreference | Tian H, McKnight SL, Russell DW. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 1997; 11: 72 ‐ 82. | en_US |
dc.identifier.citedreference | Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia‐inducible factor 1 is a basic‐helix‐loop‐helix‐PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 1995; 92: 5510 ‐ 5514. | en_US |
dc.identifier.citedreference | Wang GL, Semenza GL. Characterization of hypoxia‐inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem 1993; 268: 21513 ‐ 21518. | en_US |
dc.identifier.citedreference | Haase VH, Glickman JN, Socolovsky M, Jaenisch R. Vascular tumors in livers with targeted inactivation of the von Hippel‐Lindau tumor suppressor. Proc Natl Acad Sci U S A 2001; 98: 1583 ‐ 1588. | en_US |
dc.identifier.citedreference | Park SK, Haase VH, Johnson RS. von Hippel Lindau tumor suppressor regulates hepatic glucose metabolism by controlling expression of glucose transporter 2 and glucose 6‐phosphatase. Int J Oncol 2007; 30: 341 ‐ 348. | en_US |
dc.identifier.citedreference | Peyssonnaux C, Zinkernagel AS, Schuepbach RA, Rankin E, Vaulont S, Haase VH, et al. Regulation of iron homeostasis by the hypoxia‐inducible transcription factors (HIFs). J Clin Invest 2007; 117: 1926 ‐ 1932. | en_US |
dc.identifier.citedreference | Rankin EB, Biju MP, Liu Q, Unger TL, Rha J, Johnson RS, et al. Hypoxia‐inducible factor‐2 (HIF‐2) regulates hepatic erythropoietin in vivo. J Clin Invest 2007; 117: 1068 ‐ 1077. | en_US |
dc.identifier.citedreference | Rankin EB, Rha J, Unger TL, Wu CH, Shutt HP, Johnson RS, et al. Hypoxia‐inducible factor‐2 regulates vascular tumorigenesis in mice. Oncogene 2008; 27: 5354 ‐ 5358. | en_US |
dc.identifier.citedreference | Rankin EB, Rha J, Selak MA, Unger TL, Keith B, Liu Q, et al. Hypoxia‐inducible factor 2 regulates hepatic lipid metabolism. Mol Cell Biol 2009; 29: 4527 ‐ 4538. | en_US |
dc.identifier.citedreference | Matsusue K, Miyoshi A, Yamano S, Gonzalez FJ. Ligand‐activated PPARbeta efficiently represses the induction of LXR‐dependent promoter activity through competition with RXR. Mol Cell Endocrinol 2006; 256: 23 ‐ 33. | en_US |
dc.identifier.citedreference | Taylor M, Qu A, Anderson ER, Matsubara T, Martin A, Gonzalez FJ, et al. Hypoxia‐inducible factor‐2alpha mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice. Gastroenterology 2011; doi:10.1053/j.gastro.2011.03.007. | en_US |
dc.identifier.citedreference | Schuler M, Dierich A, Chambon P, Metzger D. Efficient temporally controlled targeted somatic mutagenesis in hepatocytes of the mouse. Genesis 2004; 39: 167 ‐ 172. | en_US |
dc.identifier.citedreference | Romeo S, Yin W, Kozlitina J, Pennacchio LA, Boerwinkle E, Hobbs HH, et al. Rare loss‐of‐function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J Clin Invest 2009; 119: 70 ‐ 79. | en_US |
dc.identifier.citedreference | Conklin D, Gilbertson D, Taft DW, Maurer MF, Whitmore TE, Smith DL, et al. Identification of a mammalian angiopoietin‐related protein expressed specifically in liver. Genomics 1999; 62: 477 ‐ 482. | en_US |
dc.identifier.citedreference | Koishi R, Ando Y, Ono M, Shimamura M, Yasumo H, Fujiwara T, et al. Angptl3 regulates lipid metabolism in mice. Nat Genet 2002; 30: 151 ‐ 157. | en_US |
dc.identifier.citedreference | Higgins DF, Kimura K, Bernhardt WM, Shrimanker N, Akai Y, Hohenstein B, et al. Hypoxia promotes fibrogenesis in vivo via HIF‐1 stimulation of epithelial‐to‐mesenchymal transition. J Clin Invest 2007; 117: 3810 ‐ 3820. | en_US |
dc.identifier.citedreference | Kagan HM. Lysyl oxidase: mechanism, regulation and relationship to liver fibrosis. Pathol Res Pract 1994; 190: 910 ‐ 919. | en_US |
dc.identifier.citedreference | Myllyharju J. Prolyl 4‐hydroxylases, the key enzymes of collagen biosynthesis. Matrix Biol 2003; 22: 15 ‐ 24. | en_US |
dc.identifier.citedreference | Strnad P, Omary MB. Transglutaminase cross‐links Sp1‐mediated transcription to ethanol‐induced liver injury. Gastroenterology 2009; 136: 1502 ‐ 1505. | en_US |
dc.identifier.citedreference | Tatsukawa H, Fukaya Y, Frampton G, Martinez‐Fuentes A, Suzuki K, Kuo TF, et al. Role of transglutaminase 2 in liver injury via cross‐linking and silencing of transcription factor Sp1. Gastroenterology 2009; 136: 1783.e10 ‐ 1795.e10. | en_US |
dc.identifier.citedreference | van der Slot AJ, Zuurmond AM, Bardoel AF, Wijmenga C, Pruijs HE, Sillence DO, et al. Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis. J Biol Chem 2003; 278: 40967 ‐ 40972. | en_US |
dc.identifier.citedreference | Lieber CS, DeCarli LM. Animal models of chronic ethanol toxicity. Meth Enzymol 1994; 233: 585 ‐ 594. | en_US |
dc.identifier.citedreference | Somsouk M, Yee HF Jr, Biggins SW. Understanding liver health using the National Center for Health Statistics. Dig Dis Sci 2009; 54: 2325 ‐ 2329. | en_US |
dc.identifier.citedreference | Day CP, James OF. Steatohepatitis: a tale of two “hits”? Gastroenterology 1998; 114: 842 ‐ 845. | en_US |
dc.identifier.citedreference | Shimizugawa T, Ono M, Shimamura M, Yoshida K, Ando Y, Koishi R, et al. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J Biol Chem 2002; 277: 33742 ‐ 33748. | en_US |
dc.identifier.citedreference | Shan L, Yu XC, Liu Z, Hu Y, Sturgis LT, Miranda ML, Liu Q. The angiopoietin‐like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms. J Biol Chem 2009; 284: 1419 ‐ 1424. | en_US |
dc.identifier.citedreference | Lee EC, Desai U, Gololobov G, Hong S, Feng X, Yu XC, et al. Identification of a new functional domain in angiopoietin‐like 3 (ANGPTL3) and angiopoietin‐like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL). J Biol Chem 2009; 284: 13735 ‐ 13745. | en_US |
dc.identifier.citedreference | Kucejova B, Sunny NE, Nguyen AD, Hallac R, Fu X, Pena‐Llopis S, et al. Uncoupling hypoxia signaling from oxygen sensing in the liver results in hypoketotic hypoglycemic death. Oncogene 2011; 30: 2147 ‐ 2160. | en_US |
dc.identifier.citedreference | Imtiyaz HZ, Williams EP, Hickey MM, Patel SA, Durham AC, Yuan LJ, et al. Hypoxia‐inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation. J Clin Invest 2010; 120: 2699 ‐ 2714. | en_US |
dc.identifier.citedreference | Copple BL, Bustamante JJ, Welch TP, Kim ND, Moon JO. Hypoxia‐inducible factor‐dependent production of profibrotic mediators by hypoxic hepatocytes. Liver Int 2009; 29: 1010 ‐ 1021. | en_US |
dc.identifier.citedreference | Copple BL, Bai S, Moon JO. Hypoxia‐inducible factor‐dependent production of profibrotic mediators by hypoxic Kupffer cells. Hepatol Res 2010; 40: 530 ‐ 539. | en_US |
dc.identifier.citedreference | Copple BL, Bai S, Burgoon LD, Moon JO. Hypoxia‐inducible factor‐1alpha regulates the expression of genes in hypoxic hepatic stellate cells important for collagen deposition and angiogenesis. Liver Int 2011; 31: 230 ‐ 244. | en_US |
dc.identifier.citedreference | Brenner DA. Molecular pathogenesis of liver fibrosis. Trans Am Clin Climatol Assoc 2009; 120: 361 ‐ 368. | en_US |
dc.identifier.citedreference | Jang GY, Jeon JH, Cho SY, Shin DM, Kim CW, Jeong EM, et al. Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF‐kappaB activity in hypoxic tumor cells. Oncogene 2010; 29: 356 ‐ 367. | en_US |
dc.identifier.citedreference | Popov Y, Sverdlov DY, Sharma AK, Bhaskar KR, Li S, Freitag TL, et al. Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice. Gastroenterology 2011; 140: 1642 ‐ 1652. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.